NeuraSignal

NovaSignal is a biotechnology and healthcare startup based in the United States, founded in 2013. In a significant development, in 2023 NeuraSignal, Inc. acquired the business of NovaSignal, the original developer of NovaGuide. NeuraSignal is a medical technology company with a mission to save lives by unlocking the power of cerebral blood flow data. The company's FDA-cleared NovaGuide Intelligent Ultrasound combines non-invasive ultrasound, robotics, and artificial intelligence to assess cerebral hemodynamics in real time. This technology, combined with cloud computing and data analytics, supports physicians in their clinical decision making in several neurological conditions including stroke, traumatic brain injury, and dementia. In its last funding round, NovaSignal secured a noteworthy $37.00M Series C investment on 28 September 2021. The investors participating in this round were Alpha Edison and Reimagined Ventures. The company's continued focus on leveraging advanced technologies to improve diagnostics and treatment in the field of neurology positions it as an attractive opportunity for investors seeking to support innovations in the healthcare industry. For further information, visit www.NeuraSignal.com.